Contact this trialFirst, we need to learn more about you.
Soluble Guanylate Cyclase Stimulator
Runcaciguat for Diabetic Retinopathy
Recruiting0 awardsPhase 2
Poway, California
This trial is testing a new drug to see if it's safe and effective in treating diabetic retinopathy, by looking at changes in the retina over time. The drug will be given for 24 weeks, and then they'll check to see if there have been any improvements.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.